View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant by Amicus Therapeutics, Inc.

Cases and Conversations: Patient-Minded Approaches to Managing Fabry Disease

Cases and Conversations: Patient-Minded Approaches to Managing Fabry Disease

Tuesday, April 14, 2020

Live Webcast: 6:00 PM - 7:30 PM EDT


Fabry disease is a rare, genetic, X-linked lysosomal storage disorder caused by absence or deficiency of the enzyme alpha-galactosidase A (α-GAL A), resulting from mutations in the GLA gene. Glycosphingolipids (Gb3 or lyso-Gb3) accumulate in the lysosomes of a variety of cells, including small blood vessels, kidneys, heart, and nervous system. This progressive lipid accumulation causes cell damage, leading to tissue remodeling, fibrosis, ischemia, and organ dysfunction. Due to the consequences of Fabry disease, early diagnosis is extremely vital in patients so effective treatment can be started. Delays in the diagnosis of Fabry disease have been attributed to the insidious development of the disease. Health care professionals often do not recognize the different manifestations of Fabry disease. The discussion will use a series of cases to foster discussion of new data and sharing of best practices that address unmet needs in Fabry disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant by Amicus Therapeutics, Inc.

Target Audience

This educational program is directed toward geneticists, genetic counselors, pediatricians, endocrinologists, primary care physicians, nurses, nurse practitioners, physician assistants, and other health care professionals who are involved in the care of patients with Fabry disease.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review the varied spectrum of phenotypic presentation and underlying genotypes in patients with Fabry disease
  • Discuss appropriate testing in the workup of patients with Fabry disease and confirmation of disease-causing GLA mutation
  • Evaluate the efficacy and safety of ERT and small molecule chaperone therapies and the treatment selection for patients with specific genotypes of Fabry disease
  • Apply clinical trial evidence and testing information to optimize the management of patients with Fabry disease

Program Chair

Dawn Jacob Laney
Dawn Jacob Laney, MS, CGC, CCRC
Assistant Professor/Genetic Counselor
Director, Emory Genetic Clinical Trials Center
Program Leader, Emory Lysosomal Storage Disease Center
Emory University
Atlanta, GA


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By